News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
In a move that will boost the production capacity of indigenously developed Covid-19 vaccine Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of Covaxin drug substance produced at its Karakapatla facility in Genome Valley to Bharat Biotech.
Bharat Biotech’s intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2 trials. This is the first of its kind COVID-19 jab to undergo human clinical trials in India. BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. BBIL has in-licensed technology from Washington University in St Louis, USA.
iSERA Biological said the company might able to deliver the drug at a tenth of the cost charged by the alternative antibody cocktail developed by pharma major Roche by the end of this year
People who received the jab against the coronavirus disease (Covid-19) outside the country will soon be able to download their vaccination certificate through the CoWin, a portal introduced by the Indian government to streamline the inoculation drive process, Livemint reported on Tuesday, quoting a government official.
NPPA monitors the ceiling price of the scheduled formulations to ensure that the MRP of such formulations are within the range of ceiling price and monitors non-scheduled formulations to ensure that their MRP does not increase by more than 10% during the preceding twelve months.
The National Telemedicine Service of the Ministry of Health & Family Welfare has completed 90 lakh teleconsultations in the country. The last 10 lakh consultations came up in record 17 days.
In a landmark initiative to ensure safety from COVID-19, Ministry of Health and Family Welfare has taken a decision to allow foreign nationals residing in India to get registered on CoWin portal to take COVID-19 vaccine. They can use their passport as identity document for the purpose of registration on CoWIN portal. Once they are registered on this portal, they will get a slot for vaccination.
Union Ayush Minister Shri Sarbananda Sonowal and MoS for Ayush, Dr. Munjapara Mahendrabhai visited All India Institute of Ayurveda on Sunday and inaugurated Multi-Purpose Yoga Hall & Mini Auditorium. Both the Ministers highly appreciated the work done by AIIA and assured their full-fledged support for further development of the Institute to make it world’s best Ayurveda Institute. Lauding the futuristic plan of the Institute, Shri Sarbananda Sonowal assured all help for establishing the first Bio-Bank of the world in Ayurveda at AIIA.
India crossed the 500 million doses mark in total vaccine shots administered so far on Friday, health minister Mansukh Mandaviya said in a tweet. “India soars high on #COVID19 vaccination, historic record of 50 crore doses administered to date,” the minister said.
‘Ashwagandha’ (Withania somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress and makes the immune system stronger. It is an easily accessible, over-the-counter nutritional supplement in the U.K. and has a proven safety profile. The positive effects of ‘Ashwagandha’ have been observed in Long COVID, which is a multi-system disease with no evidence of its effective treatment or management.
